Author:
Klein Sandra,Frame Fiona M.,Maitland Norman J.
Reference162 articles.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
3. Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V et al (2010) Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res 16:2115–2121
4. Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, Fine S, Reuter V, Scher HI, Hallden C et al (2010) Susceptibility loci associated with prostate cancer progression and mortality. Clin Cancer Res 16:2819–2832
5. Powell IJ (2011) The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis. Arch Esp Urol 64:711–719